DiscoverMedical News PodcastCGRP Migraine Therapies in 2025: Navigating New Safety Warnings for Raynaud’s Phenomenon and Hypertension
CGRP Migraine Therapies in 2025: Navigating New Safety Warnings for Raynaud’s Phenomenon and Hypertension

CGRP Migraine Therapies in 2025: Navigating New Safety Warnings for Raynaud’s Phenomenon and Hypertension

Update: 2025-09-25
Share

Description

Drs. Hindiyeh and Hutchinson review new FDA-issued safety warnings for Raynaud's phenomenon and hypertension in CGRP-based migraine treatment. They explore the impact of this label update and share practical strategies for patient management.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

CGRP Migraine Therapies in 2025: Navigating New Safety Warnings for Raynaud’s Phenomenon and Hypertension

CGRP Migraine Therapies in 2025: Navigating New Safety Warnings for Raynaud’s Phenomenon and Hypertension

PeerDirect Publishing